Stockholm Stock Exchange | Mid Cap
Immunovia
+605.88%
Latest
-
3 months
Danske Bank

Price Targets For Immunovia

AnalystPrice TargetDateUpside
Danske Bank240 SEKSep -21
+605.88%

About The Company

Immunovia AB is a Swedish listed medical technology company. The company develops tools for diagnosing diseases. Blood samples provide biomarker signatures specific to each disease. The first test concerns pancreatic cancer and is now undergoing final validation studies.
Wikipedia